https://sam.gov/opp/270aef1b0b3a4471a53d9508fb4d8268/view
Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target
Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.